Evolent And Careology Form Partnership To Enhance Cancer Care In The U.S.
- Digital cancer care platform Careology and Evolent (NYSE:EVH) to offer an innovative platform to enable cancer navigation
- Evolent will embed Careology's digital cancer care technology within its comprehensive care navigation services offered to health plan clients across the U.S.
WASHINGTON, May 9, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a $2 billion revenue company focused on achieving better health outcomes for people with complex conditions, today announced it is partnering with Careology, a digital cancer care platform, to enable more coordinated, connected and empowered journeys for people living with cancer in the U.S.
Evolent works with more than 70 health plans — spanning approximately 40 million unique members — to improve the quality and affordability of care for cancer and other conditions.
The agreement will bring together Careology's "patient-first" digital solution with Evolent's comprehensive care navigation services. The joint offering will create a platform that connects and empowers patients with personalized information and intuitive tools to understand their diagnoses and treatment regimens, as well as manage symptoms and potential treatment side-effects. These navigation capabilities will enhance Evolent's expertise in best practices and clinical pathways to guide cancer treatment and tackle preventable and costly complications.